Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
closedAccess | | dic-2021 | COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network | Ludwig, Heinz; Sonneveld, Pieter; Facon, Thierry; San Miguel, Jesús F. CSIC ORCID; Avet-Loiseau, Hervé; Mohty, Mohty, Mohamad; Mateos, Maria Victoria; Moreau, Philippe; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Engelhardt, Monika; Driessen, Christoph; Cook, Gordon; Dimopoulos, Meletios A.; Gay, Francesca; Einsele, Hermann; Delforge, Michel; Caers, Jo; Weisel, Katja C.; Jackson, Graham; Garderet, Laurent; Donk, Niels W. C. J. van de; Leleu, Xavier; Goldschmidt, Hartmut; Beksac, Meral; Nijhof, Inger; Schreder, Martin; Abildgaard, Niels; Hajek, Roman; Zojer, Niklas; Kastritis, Efstathios; Broijl, Annemiek; Schjesvold, Fredrik; Boccadoro, Mario; Terpos, Evangelos | artículo de revisión |
openAccess | | 2021 | Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR | Weisel, Katja C.; Mateos, Maria Victoria; Gay, Francesca; Delforge, Michel; Cook, Gordon; Szabo, Zsolt; Desgraz, Renaud; DeCosta, Lucy; Moreau, Philippe | artículo |
openAccess | | 2014 | Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma | Dimopoulos, Meletios A.; Palumbo, Antonio; Moreau, Philippe; Delforge, Michel; Cavo, Michele; Ludwig, Heinz; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
closedAccess | | 2011 | Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. Melphalan-prednisone in the phase III VISTA trial in multiple myeloma | Delforge, Michel; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID | artículo |
closedAccess | | 2012 | Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: Results from the VISTA trial | Delforge, Michel; San Miguel, Jesús F. CSIC ORCID | artículo |
closedAccess | | 2011 | Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: Consensus statement | Palumbo, Antonio; Delforge, Michel; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCID | artículo |
openAccess | | 1-sep-2023 | Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients | Avivi, Irit; Vesole, David H.; Dávila, Julio; Usnarska-Zubkiewicz, Lidia; Olszewska-Szopa, Magdalena; Milunovic, Vibor; Baumert, Bartłomiej; Osękowska, Bogumiła; Kopińska, Anna; Gentile, Massimo; Puertas Martínez, Borja; Robak, Paweł; Crusoe, Edvan; Rodríguez-Lobato, Luis Gerardo; Gajewska, Małgorzata; Varga, Gergely; Delforge, Michel; Cohen, Yael; Gozzetti, Alessandro; Pena, Camila; Shustik, Chaim; Mikala, Gabor; Zalac, Klara; Alexander, H. Denis; Barth, Peter; Weisel, Katja C.; Martínez-López, Joaquín; Waszczuk-Gajda, Anna; Krzystański, Mateusz; Jurczyszyn, Artur | artículo |
openAccess | | 2013 | Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma | San Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Palumbo, Antonio; Delforge, Michel; Mateos, Maria Victoria; Richardson, Paul G. | artículo |
closedAccess | | 2016 | Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma | Dimopoulos, Meletios A.; Palumbo, Antonio; Corradini, Paolo; Cavo, Michele; Delforge, Michel; Di Raimondo, Francesco; Weisel, Katja C.; Oriol, Albert; Hansson, Markus; Vacca, Angelo; Blanchard, María Jesús; Goldschmidt, Hartmut; Doyen, Chantal; Kaiser, Martin; Petrini, Mario; Anttila, Pekka; Cafro, Anna Maria; Raymakers, Reinier; San Miguel, Jesús F. CSIC ORCID; Arriba, Felipe de; Knop, Stefan; Röllig, Christoph; Ocio, Enrique M. CSIC ORCID ; Morgan, Gareth J.; Miller, Neil; Simcock, Mathew; Peluso, Teresa; Herring, Jennifer; Sternas, Lars; Zaki, Mohamed H.; Moreau, Philippe | artículo |